Jpmorgan Chase & Co »

Cogent Biosciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $582k 87k 6.72
2023-12-31 $724k 123k 5.88
2023-09-30 $2.6M 269k 9.75
2023-06-30 $3.2M 267k 11.84
2023-03-31 $2.8M 270k 10.55
2022-12-31 $2.8M 241k 11.42
2022-06-30 $3.1M 356k 8.77
2022-03-31 $1.2M 164k 7.48
2021-12-31 $1.8M 216k 8.29
2021-03-31 $2.2M 248k 8.81
2020-12-31 $776k 67k 11.54